Cargando…

Structure-based development of caged dopamine D(2)/D(3) receptor antagonists

Dopamine is a neurotransmitter of great physiological relevance. Disorders in dopaminergic signal transduction are associated with psychiatric and neurological pathologies such as Parkinson’s disease, schizophrenia and substance abuse. Therefore, a detailed understanding of dopaminergic neurotransmi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gienger, Marie, Hübner, Harald, Löber, Stefan, König, Burkhard, Gmeiner, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972920/ https://www.ncbi.nlm.nih.gov/pubmed/31965029 http://dx.doi.org/10.1038/s41598-020-57770-9

Ejemplares similares

Fluorescent ligands for dopamine D(2)/D(3) receptors
por: Allikalt, Anni, et al.
Publicado: (2020)

Visualization of ligand-induced dopamine D(2S) and D(2L) receptor internalization by TIRF microscopy
por: Tabor, Alina, et al.
Publicado: (2017)

Identification of the Beer Component Hordenine as Food-Derived Dopamine D2 Receptor Agonist by Virtual Screening a 3D Compound Database
por: Sommer, Thomas, et al.
Publicado: (2017)

Functionally selective activation of the dopamine receptor D(2) is mirrored by the protein expression profiles
por: Wenk, Deborah, et al.
Publicado: (2021)

Structure-guided development of heterodimer-selective GPCR ligands
por: Hübner, Harald, et al.
Publicado: (2016)

Optimizing the Expression of Human Dopamine Receptors in Escherichia coli
por: Boritzki, Vanessa, et al.
Publicado: (2021)

[(18)F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ-Opioid Receptor
por: Nebel, Natascha, et al.
Publicado: (2017)

The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
por: Zięba, Agata, et al.
Publicado: (2019)

Photochromic Fentanyl Derivatives for Controlled μ‐Opioid Receptor Activation
por: Lahmy, Ranit, et al.
Publicado: (2022)

Distinct Dopamine D(2) Receptor Antagonists Differentially Impact D(2) Receptor Oligomerization
por: Wouters, Elise, et al.
Publicado: (2019)

Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D(2) and D(3) Receptors
por: Newton, Claire L., et al.
Publicado: (2016)

Active-State Model of a Dopamine D(2) Receptor - Gα(i) Complex Stabilized by Aripiprazole-Type Partial Agonists
por: Kling, Ralf C., et al.
Publicado: (2014)

Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
por: Ferruz, Noelia, et al.
Publicado: (2018)

Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
por: Liu, Hongtao, et al.
Publicado: (2018)

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
por: Maramai, Samuele, et al.
Publicado: (2016)

Effects of dopamine D(4 )receptor antagonist on spontaneous alternation in rats
por: Moustgaard, Anette, et al.
Publicado: (2008)

Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response
por: Bhathena, A, et al.
Publicado: (2013)

Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
por: Budzinski, Julian, et al.
Publicado: (2021)

Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D(3) Receptor Antagonists
por: Chen, Jianyong, et al.
Publicado: (2014)

Discovery, Optimization, and Characterization of Novel D(2) Dopamine Receptor Selective Antagonists
por: Xiao, Jingbo, et al.
Publicado: (2014)

Effect of Dopamine D(2) Receptor Antagonists on [(18)F]-FEOBV Binding
por: Schildt, Anna, et al.
Publicado: (2020)

Author Correction: Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
por: Ferruz, Noelia, et al.
Publicado: (2019)

Development and Characterization of Novel Selective, Non-Basic Dopamine D(2) Receptor Antagonists for the Treatment of Schizophrenia
por: Stępnicki, Piotr, et al.
Publicado: (2023)

Single exposure of dopamine D1 antagonist prevents and D2 antagonist attenuates methylphenidate effect
por: Claussen, Catherine M, et al.
Publicado: (2015)

A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization
por: Marsango, Sara, et al.
Publicado: (2017)

In Vitro and In Silico Characterization of Kurarinone as a Dopamine D(1A) Receptor Antagonist and D(2L) and D(4) Receptor Agonist
por: Prajapati, Ritu, et al.
Publicado: (2021)

Photolysis of a Caged, Fast-Equilibrating Glutamate Receptor Antagonist, MNI-Caged γ-D-Glutamyl-Glycine, to Investigate Transmitter Dynamics and Receptor Properties at Glutamatergic Synapses
por: Palma-Cerda, Francisco, et al.
Publicado: (2018)

Analysis of Human Dopamine D(3) Receptor Quaternary Structure
por: Marsango, Sara, et al.
Publicado: (2015)

Carbazole and tetrahydro-carboline derivatives as dopamine D(3) receptor antagonists with the multiple antipsychotic-like properties
por: Li, Zhongtang, et al.
Publicado: (2023)

Effect of D1- and D2-like Dopamine Receptor Antagonists on the Rewarding and Anxiolytic Effects of Neurotensin in the Ventral Pallidum
por: Ollmann, Tamás, et al.
Publicado: (2022)

Highly Potent and Selective Dopamine D(4) Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma
por: Pavletić, Pegi, et al.
Publicado: (2022)

The effect of modafinil on the rat dopamine transporter and dopamine receptors D1–D3 paralleling cognitive enhancement in the radial arm maze
por: Karabacak, Yasemin, et al.
Publicado: (2015)

Changes of Locomotor Activity by Dopamine D2, D3 Agonist Quinpirole in Mice Using Home-cage Monitoring System
por: Park, Jeonghyun, et al.
Publicado: (2023)

Comparative MD Simulations Indicate a Dual Role for Arg132(3.50) in Dopamine-Dependent D2R Activation
por: Kling, Ralf C., et al.
Publicado: (2016)

Studies of New Fused Benzazepine as Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics
por: Liu, Jing, et al.
Publicado: (2011)

Abnormal modulation of reward versus punishment learning by a dopamine D2-receptor antagonist in pathological gamblers
por: Janssen, Lieneke Katharina, et al.
Publicado: (2015)

Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands
por: Schaab, Carolin, et al.
Publicado: (2014)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

Structure of the dopamine D(2) receptor in complex with the antipsychotic drug spiperone
por: Im, Dohyun, et al.
Publicado: (2020)

High Affinity Dopamine D(3) Receptor (D(3)R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D(3)R Knockout Mice
por: Boateng, Comfort A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1chsamlp9ct8l7ufvtufvcafva